Snowball Research
Subscribe
Sign in
Share this post
Snowball Research
Aclaris Therapeutics (ACRS) appoints a new CEO who recently served as an R&D head of $6.7 billion Arena Pharma; Many analysts are upbeat about the lead drug candidate for immuno-inflammatory diseases
Copy link
Facebook
Email
Notes
More
Aclaris Therapeutics (ACRS) appoints a new…
Apr 26
Share this post
Snowball Research
Aclaris Therapeutics (ACRS) appoints a new CEO who recently served as an R&D head of $6.7 billion Arena Pharma; Many analysts are upbeat about the lead drug candidate for immuno-inflammatory diseases
Copy link
Facebook
Email
Notes
More
This thread is only visible to paid subscribers of Snowball Research
Subscribe to view →
Comments on this post are for paid subscribers
Subscribe
Already a paid subscriber?
Sign in
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Share this post
Aclaris Therapeutics (ACRS) appoints a new…
Share this post
This thread is only visible to paid subscribers of Snowball Research
Comments on this post are for paid subscribers